The melatonin market is likely to record a valuation of USD 6.6 billion in 2035, while in 2025, it will be USD 2.8 billion. The growth provides a CAGR of 9% during the forecast period due to increasing awareness and the occurrence of sleep disorders globally.
The growing incidence of insomnia, jet lag, and general sleep disorders, coupled with the increasing preference for natural over prescription medication, are key drivers for this industry growth. Moreover, the elderly population, who inevitably suffer from decreasing levels, are key drivers for the industry for supplements, which are marketed as safer, non-addictive substitutes for traditional sleeping pills.
In addition to increasing the demand for melatonin consumption as a dietary supplement, advances in the technology of products, such as extended-release products for elderly consumers, are leading to the growth of the industry. Manufacturers like Nature's Bounty and Natrol have benefited from the demand by delivering tailor-made solutions.
The wider industry is also benefiting from the expansion of e-commerce websites where consumers can easily access a variety of products and information regarding sleep health.
Treatment of jet lag remains a lucrative segment, with business travelers seeking to use it to align their body clocks. Changes in regulation in major industries are putting supplements in a position for increased visibility, thereby expanding the industry size.
The global industry also experienced growth due to scientific evidence of its effectiveness in treating sleep disorders. Clinical evidence from reputable research and studies enhanced consumer confidence in the product, where firms such as Puritan's Pride and Solgar could sell their products with relative ease. On-going advances in delivery systems, such as increasing bioavailability, enhance the product's attractiveness and accelerate overall adoption in the industry.
Besides this, increased consumer knowledge of the negative effects of stress and its connection with sleep disorders has created additional demand for non-addictive, natural products. Combined with these shifting consumer trends, the supplements will likely control a larger portion of over-the-counter sleep aids. Overall, the trend towards more holistic health solutions also supports the projected growth of the industry.
Market Metrics
| Metrics | Values |
|---|---|
| Industry Size (2025E) | USD 2.8 billion |
| Industry Value (2035F) | USD 6.6 billion |
| CAGR (2025 to 2035) | 9% |
Over the last decade, the global industry has seen a surge in demand owing to the rising awareness among consumers regarding sleep disorders and the conversion to natural supplements away from pharmaceuticals. The travel industry remains the primary glue for the expansion of industries because consumers take melatonin to maintain sleep-wake cycles during travel times that include time shifts.
In addition, the physiological aging of the population leads to a decrease in the production, which has been the most important driving force of professional products auxiliary qualities development, especially for the elderly population, a new generation of sustained-release products. With the consumer shifting towards increasingly natural and whole health products, the industry can look forward to benefiting from the established trends around wellness and supplements.
It is non-addictive and is widely recognized as a natural remedy and both these observations are favoring consumers in the industry. This is one of the factors which has contributed to the rise, as consumer confidence has been bolstered by several other clinical trials that have demonstrated the effectiveness of the product in treating various sleep disorders.
Brands that can differentiate their products based on advanced delivery systems -such as delayed-release melatonin or promulgation combinations with other ophthalmic agents-are seeing significant industry share growth. Websites have also been key to allowing these products to be available more broadly, offering a platform for reach through direct-to-consumer sales.
With the shifting marketplace, companies are also now concerned about the ecological effect of producing and wrapping. As interest in sustainability and eco-friendly practices on the rise, companies are looking to reduce their impact and offer greener alternatives. Couple that with the rise in consumer demand for products that not only work but can also be made responsibly, and you've got the makings of a market explosion.
The below table gives an overview of the change in CAGR over six months of the base year (2024) and current year (2025) for the industry. This analysis uncovers the critical fluctuations of performance and shows the pattern of revenue realization - giving stakeholders a clearer sight on the annual growth trajectory. H1 is short for the first six months of the year, from January to June. H2, the latter half of the year, the months of July through December.
| Particular | Value CAGR |
|---|---|
| H1 (2024 to 2034) | 8.2% |
| H2 (2024 to 2034) | 8.6% |
| H1 (2025 to 2035) | 8.7% |
| H2 (2025 to 2035) | 9% |
In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 8.2%, followed by a higher growth rate of 8.6% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to increase to 8.7% in the first half and remain considerably high at 9% in the second half. In the first half (H1) the sector witnessed an increase of 50 BPS while in the second half (H2), the business witnessed an increase of 10 BPS.
Between 2020 and 2024, the industry experienced exponential growth based on increased awareness of sleep well-being among consumers and increasing occurrences of sleep disorders. Demand for supplements was driven due to lifestyle-induced stress, heightened reliance on natural sleep aids, and an aging population with sleep issues.
The COVID-19 pandemic also spurred further industry growth as customers demanded immune-stimulating and stress-reduction supplements, and the industry grew even more in demand because of its further applications aside from sleep management.
Regulatory confusion and long-term consumption concerns were challenges to industry growth despite this. Manufacturers undertook the strategy of product innovation, developing melatonin-fortified drinks, gummies, and foods for deeper mass industry penetration.
The decade from 2025 to 2035 will witness the industry develop with advancements in customized nutrition and precision medicine leading the way towards customized products of supplements. The expanded use in cognitive wellness, anti-aging, and mental health will continue to face scientific evaluation. The industry will have increased convergence of AI-powered monitoring of health to allow consumers to monitor sleep activity and control the consumption.
Regulatory rules from government agencies will also tighten to regulate the quality of the product as well as stability of the dose. Moreover, green sourcing of raw materials as well as advances in biotech will propel plant-based and synthesized substitute production.
Increasing demand from consumers for overall wellness solutions will also drive the industry forward, further expanding its appeal to emerging economies where awareness regarding sleep health is growing.
Comparative Market Shift Analysis (2020 to 2024 vs. 2025 to 2035)
| 2020 to 2024 | 2025 to 2035 |
|---|---|
| Rising sleep disorders and stress-related complications. Growing demand for natural sleep therapies. | Expansion to cognitive health and anti-aging benefits. Growth in individualized nutrition and customized supplements. |
| Shift towards non-prescription sleep therapies. Favor among melatonin-infused drinks and foods. | Integration of AI in tracking well-being. Sustained growing demand for plant-based and chemical alternatives. |
| Concerns regarding safety of dosing and long-term effects. Discrepancies in international laws surrounding supplement ingestion. | Stricter regulatory requirements in quality control. Standardization in dosing and labeling. |
| Delivery advancements. Expansion of gummy and liquid supplement industries. | Personalized supplement regimens via AI. Green production with cutting-edge biotechnology. |
| Dependence on animal sources. Challenge of maintaining consistent quality. | Increased fermentation-based melatonin use. Focus on green and ethical supply. |
| New brand launching and new product line introduction. Focus on direct-to-consumer platforms. | Expansion into the growing industries. Collaboration with technology and health firms for wellbeing solutions. |
Despite the strong growth trajectory of the world industry, several risks exist to impede its progress. Closely competitive regional regulations stand as one such risk that affects product availability as well as accessibility to the industry.
Though some industries have embraced melatonin as a food supplement, others have laws or are yet to embrace it fully, and this can slow down the growth of the industry in such regions. In addition, the long-term effects of its consumption are yet to be researched, and any new concerns about its safety or effectiveness can negatively affect consumer confidence and demand.
Another risk factor is greater competition in the dietary supplement industry. With a more crowded industry for sleep aids, brands must struggle to differentiate their products with the presence of hundreds of others. Consumers are given a wide range of options, and it becomes difficult for individual brands to be heard.
Low-cost new entrants can lead to price competition, which can be costly and detrimental to profitability for established players. Firms will be forced to innovate on a continuous basis and focus on making high-quality, science-based products in a bid to maintain industry share.
Lastly, the uncertainty of global supply chains and the likelihood of interruptions, like those due to natural disasters, geopolitical tensions, or public health emergencies, can affect the manufacturing and delivery of supplements. These interruptions can cause shortages, higher prices, and delays, which will subsequently affect the overall industry growth.
| Segment | Value Share (2025) |
|---|---|
| Pills And Capsules | 48% |
The industry is most categorized by form into pills and capsules, holding the highest segment share of 48%, with gummies and chewable products at 22%.
Pills and capsules are the most appropriate form of melatonin supplements: they are of higher potency, precise dose, and extended-release formulations. This is where major pharmaceutical and nutraceutical companies such as Natrol, NOW Foods, and Nature Made have dominated the industry, which offers different kinds of capsules targeting sleep-related problems.
Extended-release capsules such as those from Life Extension are used primarily by people who have insomnia and those with desynchronized circadian rhythms. In addition, clinical-grade capsules used in treating sleep disorders help in boosting demand in this region. The dominance of this segment continues due to the convenience of standard dosage and easy availability in pharmacies and online platforms, including Amazon and Walgreens.
The fastest-growing segment is gummies and chewables. The primary force driving this growth is the aptitude for convenient, tasty, and easy-to-take supplements. Companies like Olly, Vitafusion, and Zarbee's Naturals have begun manufacturing gummy supplements that are perfect for children, teens, and even adults who prefer it to commercially available pills.
Moreover, the growing demand for sugar-free and organic gummies drives this segment, such as those offered by SmartyPants and Nordic Naturals for clean-label, vegan-friendly products. With retail chains like Target and CVS stocking gummies and running significant online sales, the continued expansion is anticipated to continue.
| Segment | Value Share (2025) |
|---|---|
| Online Pharmacies (By Distribution Channel) | 45.3% |
While the industry has various distribution channels, online pharmacies lead the segment with 45.3% of the sales, and retail pharmacies have approximately 35%.
Melatonin supplements are sold mostly through online pharmacies, prompted by home delivery, competitive prices, and the huge range of brands available. Online stores such as Amazon, iHerb, and Walmart not only add to the sales revenue of this segment with discounts and subscriptions but also rely on customers' reviews for the decisions they make in their purchases.
It has also seen the birth of other digital health platforms such as Hims, Roman, and Nurx, which extend the reach of direct-to-consumer models and give sleep supplements like formulations a personal touch.
Retail pharmacies are also widely used as distribution sources for melatonin supplements since they tend to meet the consumers who would prefer to see and purchase their products after the recommendations by a pharmacist. CVS, Walgreens, Rite Aid, and a few others are some of the major pharmacy chains where one can find available brands of supplements such as Nature Made, Natrol, and NOW Foods.
The same applies to retail pharmacies, for they are trusted and reliable with respect to the dosage and drug-interaction guidelines given by the pharmacist regarding taking the supplements. Within supermarkets and pharmacies such as Kroger and Target, direct sales contributions to in-store pharmacies add to customer accessibility on a larger scale.
The intersection of both retail and online channel sales reflects the changing lifestyle of consumers because while online sales are increasing due to convenience, retail pharmacy outlets prefer to remain relevant for those immediate, trusted purchases.
| Countries | CAGR (2025 to 2035) |
|---|---|
| USA | 8.2% |
| UK | 7.1% |
| France | 6.9% |
| Germany | 7.4% |
| Italy | 6.8% |
| South Korea | 9.2% |
| Japan | 9% |
| China | 10.5% |
| Australia | 7.3% |
| New Zealand | 6.7% |
The USA industry is expanding steadily due to the surging incidence of sleep disorders. Sales are being propelled by the availability of melatonin in sleep wellness products such as wearable sleep tracking devices and smart beds. Greater access to melatonin-based therapy has been enabled by telemedicine, with web consults permitting direct-to-consumer supplement guidance.
Regulatory consistency, with the FDA considering it a dietary supplement, continues to be favorable for industry expansion. Additionally, increased demand for natural sleep supplements over prescription medication has placed it on a pedestal as a safer alternative, which has contributed to industry growth further.
The UK industry is dominated primarily by an increased interest in holistic health and greater concern for sleep wellness. The National Health Service (NHS) has recognized the role of melatonin in treating specific sleep disorders and encouraged regulated yet sustained consumption.
Consumers are increasingly using natural sleep solutions due to the heightened awareness of the side effects of prescription sleeping medications. Independent healthcare providers and online pharmacies have made products more available. Increased mental health consciousness has also been boosted by increased interest in sleep improvement, further driving the industry.
The growth of France in the industry is driven by its strong demand for natural and plant-sourced health supplements. French consumers prefer functional foods produced with melatonin compared to conventional pill-based supplements. The stringent regulatory framework of dietary supplements in the country ensures the quality of products, which has created consumer trust.
Moreover, the growing popularity of healthcare apps has enabled the provision of personalized sleep aid recommendations. The robustness of France's pharmaceutical sector also facilitates the development of new products like slow-release tablets and melatonin-containing herbal teas.
The advanced health infrastructure of Germany and the demand for scientifically proven wellness products have fueled the consumption. Germany's strict regulation guarantees high-quality production. Controlled dosage and clinical efficiency are the German consumer choices, and domestic industry players have spent heavily on research.
Site-based wellness offerings targeting sleep care have also triggered consumption among working professionals. Site-based comparison product shopping and review-driven scientific opinion websites have further spurred consumer awareness and availability of melatonin sleeping pills.
Italy's demand is being driven mainly by Italy's increasing age trend in populations and wealthy cultural heritage of traditional herbal medicine. Italian consumers are increasingly interested in utilizing natural remedies for sleep issues with aging, leading to a boom in demand for melatonin-containing herbal supplements.
Demand is also being spurred by the increasing strength of Mediterranean lifestyle trends, which are largely wellness and health-balance-focused. The broader direct-to-consumer visibility of health brands in Italy has also enhanced availability to the masses in the form of online health services and door-to-door delivery.
Melatonin's increasingly booming industry in South Korea is spurred by its tech-advanced health industry and increased sleep disorders based on high-stress lifestyles. The country's mature industry for skincare and wellness has also begun to include it in beauty supplements, which are popular with consumers seeking anti-aging as well as sleep benefits.
The functional beverage industry backed by melatonin is picking up steam, with urban consumers preferring it as a readily available source of sleep remedies. The increasing government investment in mental health initiatives in the form of awareness campaigns has also increased the use of sleep benefit solutions, one of which is melatonin.
Japan's industry of an aging population and cultural predisposition to functional foods have made melatonin products a good industry. Japan's nutraceuticals industry has also been leading the way in new forms of delivery, such as tea and sleeping-promoting beverages.
Japanese companies prefer products that have undergone clinical trials, and products are developed based on their unique sleeping patterns as consumers. Also, sleep well-being is the center of corporate wellness programs in Japan, and the use of melatonin in the business setting follows. The collaboration between regulation and science endorsement has also strengthened customers' confidence in the business.
China leads the global industry, driven by increasing disposable income, increased work-related stress, and increased interest in general well-being. TCM practitioners have begun combining melatonin with traditional herbal medicine, further fueling its popularity.
The e-commerce industry, particularly e-commerce platforms such as Alibaba and JD.com, has greatly contributed to access to supplements. The increased strength of online health sites, which provide AI-generated sleeping advice and individually tailored supplement suggestions, has assisted in fueling the business. Local competitors are also putting a lot of money into a lot of research to keep up with the demand for new and quality products from consumers.
The Australian industry is expanding with increasing awareness of mental health and sleep. The country has a stringent regulatory framework to make quality, science-based products available. A maximum of half of the population is reported to have sleep disturbances through non-conventional working hours and shift work; melatonin supplements are in demand.
Australia's established wellness tourism industry has also driven demand for natural sleeping remedies, with tourists looking for holistic health experiences. Telehealth consultations and online pharmacies have made it easier for products to be accessed through urban and rural industries.
New Zealand's industry continues to develop as health awareness grows and its well-established natural health sector creates demand. Plant-based products that are organic and sustainably made are an area of interest within the country, and this has driven demand for plant-based melatonin supplements.
Expanded use of it within individualized sleep health programs, often in conjunction with naturopaths, has also driven industry opportunity. In addition, increased wearable sleep tracking has stimulated data-based melatonin use, in which individuals get tailored suggestions based on sleep patterns. Telehealth services are also fueling the industry by expanding access to sleeping solutions.
The industry is filled with lively competition from traditional leaders in nutritional supplements and niche sleep aid manufacturers. These key players use many competitive routes to the industry for the expansion of industry share and consumer loyalty.
Product innovation remains the primary competitive differentiator, and thus, companies will offer new delivery systems, specific formulations, and multi-ingredient solutions to special target consumers' needs. Natrol dominates the industry by continuously expanding its portfolio, now amounting to over 15 product variants, each addressing specific sleep concerns or consumer preferences.
Brand reputation and trust most determine purchasing decisions in this hormone-based supplement category, under which quality, and safety predominate the consumer's mind. Such well-established supplement industry stalwarts like Nature's Bounty use the trust capital built in the wider supplement industry to develop consumer faith in their preparations.
More than that, third-party certification for purity and potency is increasingly taken into consideration as a competitive factor as manufacturers looking for USP verification, NSF certification and other quality assurances to differentiate their products.
Retail distribution strategies significantly determine competition among companies in the industry as they all want an Omni channel presence from the traditional pharmacy to mass merchant outlets, specialty health stores, and e-commerce platforms.
NOW Foods has expanded its industry reach through strategic linkages with most retailers while maintaining strong capabilities and presence in direct-to-consumer sales through a proprietary online platform.
Additionally, the competition has intensified mostly in digital marketing, with most brands investing heavily in educational content, sleep health resources, and targeted advertising to reach potential consumers while they are still gathering information.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Natrol (Aurobindo Pharma) | 18-22% |
| Nature’s Bounty | 15-19% |
| NOW Foods | 12-16% |
| Life Extension | 10-14% |
| Source Naturals | 8-12% |
| Other Companies (Combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Natrol (Aurobindo Pharma) | Industry leader in supplements with a focus on fast-dissolve tablets, extended-release formulas, and high-potency doses. |
| Nature’s Bounty | Offers melatonin in gummies, capsules, and rapid-dissolve formats, emphasizing natural ingredients and non-GMO certifications. |
| NOW Foods | Provides melatonin in various dosages, including combination products with magnesium and L-theanine for enhanced relaxation. |
| Life Extension | Focuses on advanced sleep formulations with sustained-release melatonin, promoting longevity and overall wellness. |
| Source Naturals | Specializes in bioavailable melatonin with time-release technology and herbal blends for sleep optimization. |
Key Company Insights
Natrol (Aurobindo Pharma) (18-22%)
As a leading brand in the USA, Natrol dominates the industry with its Fast Dissolve and Time Release melatonin tablets. The company holds NSF certification and emphasizes scientific backing for its formulations. Natrol’s acquisition by Aurobindo Pharma in 2021 has strengthened its global reach, particularly in Asia and Europe.
Nature’s Bounty (15-19%)
With a strong presence in pharmacies and online channels, Nature’s Bounty capitalizes on natural and clean-label trends. Its gummies are among the best-selling sleep aids on Amazon and Walmart, showing a preference shift toward chewable formats.
NOW Foods (12-16%)
NOW Foods differentiates itself with affordable, high-quality supplements, offering pure powder and combination sleep aids. The brand is recognized for its GMP-certified manufacturing and broad appeal among cost-conscious consumers.
Life Extension (10-14%)
Known for research-backed formulations, Life Extension integrates it with nutraceuticals for anti-aging. Its Extended Release Melatonin and Enhanced Sleep Without Grogginess products target longevity-focused consumers.
Source Naturals (8-12%)
Pioneering time-release technology, Source Naturals has a strong reputation for holistic wellness solutions. Its products are widely available in natural food stores and integrative health clinics.
Other Key Players (30-40% Combined)
Table 1: Global Market Value (US$ million) Forecast by Region, 2018 to 2033
Table 2: Global Market Volume (MT) Forecast by Region, 2018 to 2033
Table 3: Global Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 4: Global Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 5: Global Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 6: Global Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 7: Global Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 8: Global Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 9: North America Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 10: North America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 11: North America Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 12: North America Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 13: North America Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 14: North America Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 15: North America Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 16: North America Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 17: Latin America Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 18: Latin America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 19: Latin America Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 20: Latin America Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 21: Latin America Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 22: Latin America Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 23: Latin America Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 24: Latin America Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 25: Europe Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 26: Europe Market Volume (MT) Forecast by Country, 2018 to 2033
Table 27: Europe Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 28: Europe Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 29: Europe Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 30: Europe Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 31: Europe Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 32: Europe Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 33: East Asia Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 34: East Asia Market Volume (MT) Forecast by Country, 2018 to 2033
Table 35: East Asia Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 36: East Asia Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 37: East Asia Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 38: East Asia Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 39: East Asia Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 40: East Asia Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 41: South Asia Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 42: South Asia Market Volume (MT) Forecast by Country, 2018 to 2033
Table 43: South Asia Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 44: South Asia Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 45: South Asia Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 46: South Asia Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 47: South Asia Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 48: South Asia Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 49: Oceania Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 50: Oceania Market Volume (MT) Forecast by Country, 2018 to 2033
Table 51: Oceania Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 52: Oceania Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 53: Oceania Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 54: Oceania Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 55: Oceania Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 56: Oceania Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Table 57: Middle East and Africa Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 58: Middle East and Africa Market Volume (MT) Forecast by Country, 2018 to 2033
Table 59: Middle East and Africa Market Value (US$ million) Forecast by Product Type, 2018 to 2033
Table 60: Middle East and Africa Market Volume (MT) Forecast by Product Type, 2018 to 2033
Table 61: Middle East and Africa Market Value (US$ million) Forecast by Nature, 2018 to 2033
Table 62: Middle East and Africa Market Volume (MT) Forecast by Nature, 2018 to 2033
Table 63: Middle East and Africa Market Value (US$ million) Forecast by Treatment Type, 2018 to 2033
Table 64: Middle East and Africa Market Volume (MT) Forecast by Treatment Type, 2018 to 2033
Figure 1: Global Market Value (US$ million) by Product Type, 2023 to 2033
Figure 2: Global Market Value (US$ million) by Nature, 2023 to 2033
Figure 3: Global Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 4: Global Market Value (US$ million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Volume (MT) Analysis by Region, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 10: Global Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 13: Global Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 14: Global Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 17: Global Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 18: Global Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 21: Global Market Attractiveness by Product Type, 2023 to 2033
Figure 22: Global Market Attractiveness by Nature, 2023 to 2033
Figure 23: Global Market Attractiveness by Treatment Type, 2023 to 2033
Figure 24: Global Market Attractiveness by Region, 2023 to 2033
Figure 25: North America Market Value (US$ million) by Product Type, 2023 to 2033
Figure 26: North America Market Value (US$ million) by Nature, 2023 to 2033
Figure 27: North America Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 28: North America Market Value (US$ million) by Country, 2023 to 2033
Figure 29: North America Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 30: North America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 33: North America Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 34: North America Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 37: North America Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 38: North America Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 39: North America Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 40: North America Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 41: North America Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 42: North America Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 43: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 44: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 45: North America Market Attractiveness by Product Type, 2023 to 2033
Figure 46: North America Market Attractiveness by Nature, 2023 to 2033
Figure 47: North America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 48: North America Market Attractiveness by Country, 2023 to 2033
Figure 49: Latin America Market Value (US$ million) by Product Type, 2023 to 2033
Figure 50: Latin America Market Value (US$ million) by Nature, 2023 to 2033
Figure 51: Latin America Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 52: Latin America Market Value (US$ million) by Country, 2023 to 2033
Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 54: Latin America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 57: Latin America Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 58: Latin America Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 61: Latin America Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 62: Latin America Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 65: Latin America Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 66: Latin America Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 69: Latin America Market Attractiveness by Product Type, 2023 to 2033
Figure 70: Latin America Market Attractiveness by Nature, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 73: Europe Market Value (US$ million) by Product Type, 2023 to 2033
Figure 74: Europe Market Value (US$ million) by Nature, 2023 to 2033
Figure 75: Europe Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 76: Europe Market Value (US$ million) by Country, 2023 to 2033
Figure 77: Europe Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 78: Europe Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 82: Europe Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 83: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 84: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 85: Europe Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 86: Europe Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 87: Europe Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 88: Europe Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 89: Europe Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 90: Europe Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 93: Europe Market Attractiveness by Product Type, 2023 to 2033
Figure 94: Europe Market Attractiveness by Nature, 2023 to 2033
Figure 95: Europe Market Attractiveness by Treatment Type, 2023 to 2033
Figure 96: Europe Market Attractiveness by Country, 2023 to 2033
Figure 97: East Asia Market Value (US$ million) by Product Type, 2023 to 2033
Figure 98: East Asia Market Value (US$ million) by Nature, 2023 to 2033
Figure 99: East Asia Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 100: East Asia Market Value (US$ million) by Country, 2023 to 2033
Figure 101: East Asia Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 102: East Asia Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 103: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 104: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 105: East Asia Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 106: East Asia Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 107: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 109: East Asia Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 110: East Asia Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 111: East Asia Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 112: East Asia Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 113: East Asia Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 114: East Asia Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 115: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 117: East Asia Market Attractiveness by Product Type, 2023 to 2033
Figure 118: East Asia Market Attractiveness by Nature, 2023 to 2033
Figure 119: East Asia Market Attractiveness by Treatment Type, 2023 to 2033
Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 121: South Asia Market Value (US$ million) by Product Type, 2023 to 2033
Figure 122: South Asia Market Value (US$ million) by Nature, 2023 to 2033
Figure 123: South Asia Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 124: South Asia Market Value (US$ million) by Country, 2023 to 2033
Figure 125: South Asia Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 126: South Asia Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 127: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 128: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 129: South Asia Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 130: South Asia Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 131: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 132: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 133: South Asia Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 134: South Asia Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 135: South Asia Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 136: South Asia Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 137: South Asia Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 138: South Asia Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 139: South Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 140: South Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 141: South Asia Market Attractiveness by Product Type, 2023 to 2033
Figure 142: South Asia Market Attractiveness by Nature, 2023 to 2033
Figure 143: South Asia Market Attractiveness by Treatment Type, 2023 to 2033
Figure 144: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 145: Oceania Market Value (US$ million) by Product Type, 2023 to 2033
Figure 146: Oceania Market Value (US$ million) by Nature, 2023 to 2033
Figure 147: Oceania Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 148: Oceania Market Value (US$ million) by Country, 2023 to 2033
Figure 149: Oceania Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 150: Oceania Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 151: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 152: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 153: Oceania Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 154: Oceania Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 155: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 156: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 157: Oceania Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 158: Oceania Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 159: Oceania Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 160: Oceania Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 161: Oceania Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 162: Oceania Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 165: Oceania Market Attractiveness by Product Type, 2023 to 2033
Figure 166: Oceania Market Attractiveness by Nature, 2023 to 2033
Figure 167: Oceania Market Attractiveness by Treatment Type, 2023 to 2033
Figure 168: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 169: Middle East and Africa Market Value (US$ million) by Product Type, 2023 to 2033
Figure 170: Middle East and Africa Market Value (US$ million) by Nature, 2023 to 2033
Figure 171: Middle East and Africa Market Value (US$ million) by Treatment Type, 2023 to 2033
Figure 172: Middle East and Africa Market Value (US$ million) by Country, 2023 to 2033
Figure 173: Middle East and Africa Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 174: Middle East and Africa Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 177: Middle East and Africa Market Value (US$ million) Analysis by Product Type, 2018 to 2033
Figure 178: Middle East and Africa Market Volume (MT) Analysis by Product Type, 2018 to 2033
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 181: Middle East and Africa Market Value (US$ million) Analysis by Nature, 2018 to 2033
Figure 182: Middle East and Africa Market Volume (MT) Analysis by Nature, 2018 to 2033
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Nature, 2023 to 2033
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Nature, 2023 to 2033
Figure 185: Middle East and Africa Market Value (US$ million) Analysis by Treatment Type, 2018 to 2033
Figure 186: Middle East and Africa Market Volume (MT) Analysis by Treatment Type, 2018 to 2033
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 189: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033
Figure 190: Middle East and Africa Market Attractiveness by Nature, 2023 to 2033
Figure 191: Middle East and Africa Market Attractiveness by Treatment Type, 2023 to 2033
Figure 192: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
The industry is expected to reach USD 2.8 billion in 2025.
The industry is projected to grow to USD 6.6 billion by 2035.
China is expected to experience significant growth with a 10.5% CAGR during the forecast period.
The pills and capsules segment is one of the most popular categories in the industry.
Leading companies include Natrol (Aurobindo Pharma), Nature’s Bounty, NOW Foods, Life Extension, Source Naturals, Puritan’s Pride, GNC Holdings, Jamieson Laboratories, Pharmavite (Nature Made), and Solgar.
Explore Similar Insights
Melatonin Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
